Hi skinnygirl,
True, the potential commercialisation and revenue is a few years off, but perhaps you underrate the value of 'confirmation of success', because prior to 'revenue, this is exactly what the PRR value proposition is all about.
The fact some of us reasonably think the results will be good is immaterial and no substitute for a statistically valid demonstration of success.
The value of PRR to potential investors hinges on how likely eventual commercialisation becomes and that is why these Oct anns are important.
Traders will trade and that has transitory effects on lots of shares, especially speculative shares like PRR, but 'confirmation of success' remains the key 'value' issue.
It's all about how more likely eventual commercialisation becomes at each stage and this is an important stage with potential for expedited development with orphan status and all - although phase III will still take a while.
- Forums
- ASX - By Stock
- IMM
- have my doubts
have my doubts, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
40.5¢ |
Change
0.005(1.25%) |
Mkt cap ! $588.3M |
Open | High | Low | Value | Volume |
40.0¢ | 40.5¢ | 39.8¢ | $2.431M | 6.045M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6880 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 85353 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6880 | 0.400 |
3 | 153861 | 0.395 |
5 | 142266 | 0.390 |
5 | 73412 | 0.385 |
11 | 201885 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 85353 | 3 |
0.410 | 269251 | 11 |
0.415 | 239943 | 10 |
0.420 | 492300 | 8 |
0.425 | 50700 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
NEWS
First paediatric clinical site activated – major recruitment milestone and key appointment announced
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
IMM (ASX) Chart |